Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters
| dc.citation.volume | 3 | pt_BR |
| dc.contributor.author | Ferreira, Rodrigo S [UNIFESP] | |
| dc.contributor.author | Lira, André L [UNIFESP] | |
| dc.contributor.author | Sousa, Alioscka A [UNIFESP] | |
| dc.contributor.authorLattes | http://lattes.cnpq.br/1447746283394507 | pt_BR |
| dc.date.accessioned | 2021-06-21T18:28:44Z | |
| dc.date.available | 2021-06-21T18:28:44Z | |
| dc.date.issued | 2021-04-28 | |
| dc.description.abstract | The use of nanoparticles (NPs) in biomedicine has made a gradual transition from proof-of-concept to clinical applications, with several NP types meeting regulatory approval or undergoing clinical trials. A new type of metallic nanostructures called ultrasmall nanoparticles (usNPs) and nanoclusters (NCs), while retaining essential properties of the larger (classical) NPs, have features common to bioactive proteins. This combination expands the potential use of usNPs and NCs to areas of diagnosis and therapy traditionally reserved for small-molecule medicine. Their distinctive physicochemical properties can lead to unique in vivo behaviors, including improved renal clearance and tumor distribution. Both the beneficial and potentially deleterious outcomes (cytotoxicity, inflammation) can, in principle, be controlled through a judicious choice of the nanocore shape and size, as well as the chemical ligands attached to the surface. At present, the ability to control the behavior of usNPs is limited, partly because advances are still needed in nanoengineering and chemical synthesis to manufacture and characterize ultrasmall nanostructures and partly because our understanding of their interactions in biological environments is incomplete. This review addresses the second limitation. We review experimental and computational methods currently available to understand molecular mechanisms, with particular attention to usNP–protein complexation, and highlight areas where further progress is needed. We discuss approaches that we find most promising to provide relevant molecular-level insight for designing usNPs with specific behaviors and pave the way to translational applications. | en |
| dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | pt_BR |
| dc.description.sponsorshipID | 2019/04372-6 | pt_BR |
| dc.format.extent | 2995-3027 | pt_BR |
| dc.identifier | https://pubs.rsc.org/en/content/articlehtml/2021/na/d1na00086a | pt_BR |
| dc.identifier.doi | 10.1039/D1NA00086A | pt_BR |
| dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/61068 | |
| dc.language | eng | pt_BR |
| dc.publisher | Royal Society of Chemistry | en |
| dc.relation.ispartof | Nanoscale Advances | en |
| dc.rights | info:eu-repo/semantics/openAccess | pt_BR |
| dc.subject | Ultrasmall nanoparticles | en |
| dc.subject | Nanoclusters | en |
| dc.subject | Interactions | en |
| dc.title | Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters | en |
| dc.title.alternative | Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters | en |
| dc.type | info:eu-repo/semantics/article | pt_BR |
| unifesp.campus | Escola Paulista de Medicina (EPM) | pt_BR |
| unifesp.departamento | Bioquímica | pt_BR |